President and Fellows of Harvard College
Date of Award
Type 1 Diabetes, Prevent & Delay
Term of Grant
Genetically Modified Human Cell Lines to Characterize Stem Cell-derived Beta Cells, Reconstruct Islets and Confer Immune Protection
Funding to Dr. Douglas Melton to produce insulin-producing cells as a potential therapy for type 1 diabetes.